Dogwood Therapeutics (DWTX) Assets Average (2021 - 2026)

Dogwood Therapeutics (DWTX) has reported Assets Average for 6 consecutive years, with $92.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Assets Average fell 3.09% year-over-year to $92.7 million; the TTM figure through Mar 2026 stood at $92.7 million (down 3.09% YoY), while the FY2025 annual figure was $92.2 million, up 87.34% from the prior year.
• Assets Average advanced to $92.7 million in Q1 2026 per DWTX's latest filing, from $91.1 million in the prior quarter.
• Across five years, Assets Average topped out at $96.8 million in Q2 2025 and bottomed at $3.0 million in Q3 2024.
• Historically, Assets Average has averaged $35.1 million across 5 years, with a median of $9.9 million in 2022.
• Annual changes were most pronounced in 2022 — Assets Average tumbled 58.51% — and 2025, when it soared 3087.71%.
• Dogwood Therapeutics' Assets Average stood at $9.6 million in 2022, then sank by 51.04% to $4.7 million in 2023, then surged by 926.0% to $48.3 million in 2024, then jumped by 88.59% to $91.1 million in 2025, then gained by 1.77% to $92.7 million in 2026.
• Business Quant data shows DWTX's Assets Average at $92.7 million in Q1 2026, $91.1 million in Q4 2025, and $94.3 million in Q3 2025.